ATLO vs VRTX · P/E 15, rev $45.5M vs P/E 30, rev $3.33B
Ames National Corporation (ATLO) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Ames National Corporation (ATLO) is a banks - regional company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported ATLO revenue for 2026-06-30 was $45.5M. Net income was $11.9M. ATLO currently screens at market cap $165.7M and trailing P/E 14.6.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
ATLO currently screens at market cap $165.7M and trailing P/E 14.6. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the ATLO and VRTX stock pages for the full models.
Not investment advice.